Physician Assistant in Bandera, TX Accepting Medicare
7 Physician Assistant nurses found. Showing 1 - 7
 Ms. Barbara Dorothea Dauerty, P.A. Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 1116 12th Street Suite # 3, Bandera, TX 78003 Phone: 830-796-3448 Fax: 830-796-3840 |
 Robert Schonhoff Iii, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1050 Hwy 16 S, Bandera, TX 78003 Phone: 830-796-7713 |
Nicole Mcelaney, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1050 Hwy 16 S, Bandera, TX 78003 Phone: 830-796-7713 Fax: 830-796-7744 |
Mrs. Leah Bucholz, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 756 Purple Sage Rd, Bandera, TX 78003 Phone: 830-225-1622 Fax: 830-460-5055 |
Brandon James Lang, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1050 Hwy 16 S, Bandera, TX 78003 Phone: 830-796-7713 |
Shelby Lynn Willingham, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1050 Tx-16, Bandera, Tx 78003, 1050 Tx-16, Bandera, TX 78003 Phone: 210-695-1900 |
Jesse Allan Boutwell, PHYSICIAN ASSISTANT Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1050 State Highway 16 S, Bandera, TX 78003 Phone: 830-261-0684 |
News Archive
Spectrum Pharmaceuticals initiates enrollment in Phase 2b ozarelix study for prostate cancer
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
First drug-candidate compounds discovered using AI licensed for development
Insilico Medicine, Inc., a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, announces that Juvenescence.AI, its joint venture with Juvenescence Limited, has licensed its first compound family for clinical development.
Early-onset familial Alzheimer disease provides clues to treatment of common Alzheimer's
The rarest kind of Alzheimer Disease (AD) - the form that transmits from parent to child with a cruel 50 percent likelihood - has been valued for its potential to shed light for the millions of people affected by the common form of AD.
Brains respond differently to thirst depending upon age
Twelve healthy subjects in their 60s and 70s showed a different pattern of brain activations during thirst and satiation than did 10 healthy subjects in their 20s who drank the same amounts and underwent imaging with positron-emission tomography (PET).
› Verified 8 days ago
Nurse Practitioner
Physician Assistant
Licensed Vocational Nurse